Patents-Review.com
🔗 Permalink
Assignee profile:

AskGene Pharma, Inc.

City:

Camarillo, California

Country:

United States

Published Applications:

27

Last publication date:

2025-04-24

Patent Grants:

11

Last grant date:

2025-05-27

Top Inventors for applications by AskGene Pharma, Inc.

These are the the leading inventors for applications assigned to AskGene Pharma, Inc.:

Recent patent applications by AskGene Pharma, Inc.

AskGene Pharma, Inc. based in Camarillo, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-04-24
US20250127858A1
Human necessities

NOVEL CYTOKINE PRODRUGS

 #2 | 2025-02-13
US20250051413A1
Chemistry; metallurgy

CHIMERIC MOLECULES COMPRISING IL-12 AGONIST POLYPEPTIDE

 #3 | 2024-03-28
US20240101655A1
Chemistry; metallurgy

Novel Angiopoietin 2, VEGF Dual Antagonists

 #4 | 2024-03-07
US20240076355A1
Chemistry; metallurgy

Interferon Prodrugs and Methods of Making and Using the Same

 #5 | 2024-03-07
US20240076331A1
Chemistry; metallurgy

Chimeric Molecules Comprising an IL-10 or TGF-Beta Agonist Polypeptide

 #6 | 2024-02-29
US20240067739A1
Chemistry; metallurgy

NOVEL IL-15 PRODRUGS AND METHODS OF USE THEREOF

 #7 | 2023-09-28 ✅ Patent 12,312,413 granted on 2025-05-27
US20230303714A1
Chemistry; metallurgy

Antibodies and methods for making and using the same

 #8 | 2023-05-04
US20230135521A1
Human necessities

PHARMACEUTICAL FORMULATIONS FOR NOVEL FELINE ERYTHROPOIETIN RECEPTOR AGONISTS

 #9 | 2023-04-06 ✅ Patent 12,600,762 granted on 2026-04-14
US20230108562A1
Chemistry; metallurgy

NOVEL MASKED CYTOKINES AND METHODS OF USE THEREOF

 #10 | 2022-11-10
US20220356221A1
Chemistry; metallurgy

CYTOKINE PRODRUGS AND DUAL-PRODRUGS

 #11 | 2022-09-29
US20220306714A1
Chemistry; metallurgy

IL-2 FUSION PROTEINS THAT PREFERENTIALLY BIND IL-2RALPHA

 #12 | 2022-09-15
US20220289822A1
Chemistry; metallurgy

NOVEL IL-21 PRODRUGS AND METHODS OF USE THEREOF

 #13 | 2022-02-10 ✅ Patent 12,043,662 granted on 2024-07-23
US20220041705A1
Chemistry; metallurgy

Angiopoietin 2, VEGF dual antagonists

 #14 | 2021-08-26
US20210260163A1
Human necessities

NOVEL CYTOKINE PRODRUGS

 #15 | 2021-06-03 ✅ Patent 12,459,980 granted on 2025-11-04
US20210163562A1
Chemistry; metallurgy

Novel IL-21 Prodrugs and Methods of Use Thereof

 #16 | 2020-12-17 ✅ Patent 11,845,801 granted on 2023-12-19
US20200392235A1
Chemistry; metallurgy

IL-15 prodrugs and methods of use thereof

 #17 | 2020-04-30 ✅ Patent 11,746,147 granted on 2023-09-05
US20200131260A1
Chemistry; metallurgy

Angiopoietin 2, VEGF dual antagonists

 #18 | 2020-04-02 ✅ Patent 11,059,885 granted on 2021-07-13
US20200102381A1
Chemistry; metallurgy

Angiopoietin 2, VEGF dual antagonists

 #19 | 2020-02-06 ✅ Patent 11,505,618 granted on 2022-11-22
US20200040101A1
Chemistry; metallurgy

Antibodies and methods for making and using the same

 #20 | 2019-08-15
US20190248858A1
Chemistry; metallurgy

NOVEL FELINE ERYTHROPOIETIN RECEPTOR AGONISTS

 #21 | 2019-04-11
US20190106494A1
Chemistry; metallurgy

PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis

 #22 | 2018-03-01
US20180055944A1
Human necessities

NOVEL ANTIBODY-ALBUMIN-DRUG CONJUGATES (AADC) AND METHODS FOR USING THEM

 #23 | 2018-01-11
US20180009869A1
Chemistry; metallurgy

Fusion Protein Comprising Leptin and Methods for Producing and Using the Same

 #24 | 2017-12-14 ✅ Patent 10,077,308 granted on 2018-09-18
US20170355770A1
Chemistry; metallurgy

PD-L1 specific monoclonal antibodies for disease treatment and diagnosis

 #25 | 2017-11-16 ✅ Patent 10,654,922 granted on 2020-05-19
US20170327569A1
Chemistry; metallurgy

Angiopoietin 2, VEGF dual antagonists

 #26 | 2016-05-19
US20160137712A1
Chemistry; metallurgy

Fusion Proteins With Dual Receptor Agonist Activities

 #27 | 2016-03-24 ✅ Patent 10,287,336 granted on 2019-05-14
US20160083444A1
Chemistry; metallurgy

Feline erythropoietin receptor agonists

Also check out AskGene Pharma Inc.'s (Camarillo, United States) applicant profile with 18 patent applications submitted.

AssigneeID:

106517 ⎘